Clinical Trial Update: Genetic Basis of Immunodeficiency

View source ↗

Summary

This update describes an NHLBI-funded study investigating the genetic basis of severe combined immunodeficiency (SCID) that is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Combined Immunodeficiency

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Severe Combined Immunodeficiency | Status: RECRUITING